Intervention Review

Zotepine for schizophrenia

  1. Prasanna DeSilva1,*,
  2. Mark Fenton2,
  3. John Rathbone3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 18 OCT 2006

Assessed as up-to-date: 23 AUG 2006

DOI: 10.1002/14651858.CD001948.pub2

How to Cite

DeSilva P, Fenton M, Rathbone J. Zotepine for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001948. DOI: 10.1002/14651858.CD001948.pub2.

Author Information

  1. 1

    Whitby, Yorkshire, UK

  2. 2

    National Institute for Health and Clinical Excellence, Database of Uncertainties about the Effects of Treatments (DUETs), Manchester, UK

  3. 3

    The University of Sheffield, HEDS, ScHARR, Sheffield, UK

*Prasanna DeSilva, The Anchorage, 11 Byland Road, Whitby, Yorkshire, YO21 1JH, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006


  1. Current Version

    Zotepine for schizophrenia

    Prasanna DeSilva, Mark Fenton and John Rathbone

    Version of Record online: 18 OCT 2006 | DOI: 10.1002/14651858.CD001948.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Zotepine for schizophrenia

    S Morris, A Bagnall, SJ Cooper, P DeSilva, M Fenton, GO Gammelin and M Leitner

    Version of Record online: 24 JAN 2000 | DOI: 10.1002/14651858.CD001948